Red blood cell thiopurine methyltransferase activity (TPMT) for patients who developed a second malignant neoplasm compared with patients who did not. Nine patients developed a SMN (right) compared with 515 patients who did not (left). Each dot represents 1 patient (median, 12.1 vs 18.1 IU/mL; P = .02).